Agenus | AGEN - Market Capitalization


Agenus reported $2.04B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Agenus USD 107M 16M Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Celldex Therapeutics USD 1.81B 87M Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Glaxosmithkline GBP 99.93B 13.05B Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
J&J USD 578.59B 562M Apr/2026
Karyopharm Therapeutics USD 652M 517M Apr/2026
MacroGenics USD 102M 4M Dec/2025
Merck EUR 53.3B 5.72B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Northwest Biotherapeutics USD 246M 110M Apr/2026
Novartis USD 292.21B 26.55B Dec/2025
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Veracyte USD 3.33B 627M Dec/2025